Related Experiment Video
Updated: May 10, 2026

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
Comparison of cardioprotective effects of volatile anesthetics in children undergoing ventricular septal defect
Pooja Singh1, Sandeep Chauhan, Gaurav Jain
1Department of Cardiac Anaesthesia, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. docanesthesia@gmail.com
Insights
Volatile anesthetics like isoflurane, sevoflurane, and desflurane protect children's hearts during surgery. These agents significantly reduced cardiac enzyme release compared to placebo, indicating effective cardioprotection.
Area of Science:
- Cardiology
- Anesthesiology
- Pediatric Surgery
Background:
- Volatile anesthetic agents are known to precondition the myocardium, offering protection against ischemia and infarction.
- While cardioprotective effects of volatile anesthetics are established in adults, their use in pediatric populations remains under-investigated.
- This study investigates the cardioprotective potential of three volatile anesthetic agents in children undergoing cardiac surgery.
Purpose of the Study:
- To compare the cardioprotective effects of isoflurane, sevoflurane, and desflurane in pediatric patients undergoing ventricular septal defect closure.
- To evaluate the impact of volatile anesthetic preconditioning on postoperative cardiac enzyme release (CK-MB) and clinical outcomes.
- To assess other variables associated with cardioprotection, including duration of inotropic support, mechanical ventilation, and intensive care unit (ICU) stay.
Main Methods:
- Eighty pediatric patients undergoing ventricular septal defect closure were randomized into four groups: isoflurane, sevoflurane, desflurane, or placebo (oxygen-air).
- Preconditioning with one minimum alveolar concentration (MAC) of the assigned agent was administered for five minutes post-cardiopulmonary bypass (CPB) initiation.
- Plasma creatine kinase MB (CK-MB) levels were measured at baseline, and 6 and 24 hours post-ICU admission. Clinical outcomes were also recorded.
Main Results:
- Preconditioning with isoflurane, sevoflurane, and desflurane significantly reduced postoperative CK-MB release at 6 and 24 hours compared to the placebo group.
- No significant differences in CK-MB levels were observed among the three volatile anesthetic agents.
- The placebo group showed trends towards longer durations of inotropic support, mechanical ventilation, and ICU stay, though not statistically significant.
Conclusions:
- Volatile anesthetics demonstrate significant cardioprotective effects in the pediatric myocardium during cardiac surgery.
- Isoflurane, sevoflurane, and desflurane appear equally effective in providing this cardioprotection.
- Further research is needed to determine the optimal preconditioning agent among these volatile anesthetics.
Background:
Volatile anesthetic agents may precondition the myocardium and protect against ischemia and infarction. Preconditioning by volatile anesthetic agents is well documented in adults but is underinvestigated in children. The present study compares the effect of preconditioning in children by three volatile anesthetic agents along with several other variables associated with cardioprotection.
Method:
Eighty children scheduled for ventricular septal defect closure under cardioplegic arrest were assigned to preconditioning for five minutes after commencement of cardiopulmonary bypass (CPB) with one minimum alveolar concentration (MAC) of one of the following agents: isoflurane, sevoflurane, desflurane, or placebo (oxygen-air mixture). The plasma concentration of creatine kinase MB (CK-MB) was determined after initiation of CPB, and again 6 and 24 hours after admission to the intensive care unit (ICU) after surgery. Duration of inotropic support, mechanical ventilation, and length of ICU stay in all the groups were also recorded.
Results:
Preconditioning with isoflurane, sevoflurane, and desflurane was associated with significantly decreased postoperative release of CK-MB as compared to placebo group at 6 (group 1: 237.2 ± 189, group 2: 69.8 ± 15.8, group 3: 64.7 ± 37.8, and group 4: 70.4 ± 26.7) and 24 hours (group 1: 192.4 ± 158.2, group 2: 67.7 ± 25.0, group 3: 85.7 ± 66.8, and group 4: 50.4 ± 31.6) after admission to ICU. No significant differences were observed in the CK-MB levels among the three volatile anesthetic agents. Duration of inotropic support, mechanical ventilation, and length of ICU stay were greater in placebo group as compared to other groups without reaching statistical significance.
Conclusion:
Volatile anesthetic appear to provide definite cardioprotection to pediatric myocardium. No conclusion can be drawn regarding the best preconditioning agent among isoflurane, sevoflurane, and desflurane.
Related Concept Videos
Parenteral Anesthetics: Overview
Cardiopulmonary Resuscitation IV: Pharmacological Management
Inhalational Anesthetics: Overview
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation III: AED Use